{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:24:13Z","timestamp":1789989853624,"version":"4.0.1"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.01063","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T04:27:53Z","timestamp":1543984073000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in C9orf72"],"prefix":"10.3389","volume":"9","author":[{"given":"Mary Kay","family":"Floeter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania F.","family":"Gendron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(12)70014-5","article-title":"Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study","volume":"11","author":"Byrne","year":"2012","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"B4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(14)70233-9","article-title":"C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis","volume":"14","author":"Rohrer","year":"2015","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00401-011-0907-y","article-title":"Clinical and neuropathologic heterogeneity of c9FTD\/ALS associated with hexanucleotide repeat expansion in C9ORF72","volume":"122","author":"Murray","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-013-1181-y","article-title":"Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations","volume":"126","author":"Mackenzie","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40478-018-0564-7","article-title":"Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease","volume":"6","author":"Sakae","year":"2018","journal-title":"Acta Neuropathol Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-015-1450-z","article-title":"Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing","volume":"130","author":"Schludi","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1007\/s11682-018-9837-9","article-title":"Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study","volume-title":"Brain Imaging Behav.","author":"Bede","year":""},{"key":"B10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JAD-180053","article-title":"Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three main forms of genetic frontotemporal dementia in the GENFI cohort","volume":"65","author":"Sellami","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neurobiolaging.2017.05.024","article-title":"Structural and functional brain signatures of C9orf72 in motor neuron disease","volume":"57","author":"Agosta","year":"2017","journal-title":"Neurobiol Aging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1212\/WNL.0b013e31829c5eee","article-title":"Multiparametric MRI study of ALS stratified for the C9orf72 genotype","volume":"81","author":"Bede","year":"2013","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.nicl.2016.10.014","article-title":"Longitudinal imaging in C9orf72 mutation carriers: relationship to phenotype","volume":"12","author":"Floeter","year":"2016","journal-title":"Neuroimage Clin."},{"key":"B14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/21678421.2017.1332077","article-title":"Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study","volume":"18","author":"Omer","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jnnp-2012-303507","article-title":"Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis","volume":"84","author":"Irwin","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/brain\/awr361","article-title":"Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features","volume":"135","author":"Mahoney","year":"2012","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/alzrt144","article-title":"Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions","volume":"4","author":"Mahoney","year":"2012","journal-title":"Alzheimers Res Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/WNL.0000000000001495","article-title":"C9orf72 promoter hypermethylation is neuroprotective: neuroimaging and neuropathologic evidence","volume":"84","author":"McMillan","year":"2015","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/brain\/aws001","article-title":"Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics","volume":"135","author":"Whitwell","year":"2012","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/brain\/awu248","article-title":"Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion","volume":"137","author":"Lee","year":"2014","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neurobiolaging.2017.10.008","article-title":"Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study","volume":"62","author":"Cash","year":"2018","journal-title":"Neurobiol Aging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1212\/WNL.0b013e318268452e","article-title":"Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features","volume":"79","author":"Sha","year":"2012","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1212\/WNL.0000000000004393","article-title":"Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion","volume":"89","author":"Papma","year":"2017","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.nicl.2018.02.017","article-title":"Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers","volume":"18","author":"Popuri","year":"2018","journal-title":"Neuroimage Clin."},{"key":"B25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(14)70324-2","article-title":"Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis","volume":"14","author":"Rohrer","year":"2015","journal-title":"Lancet Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1212\/WNL.0000000000002135","article-title":"Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers","volume":"85","author":"Walhout","year":"2015","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.nicl.2018.02.019","article-title":"Thalamic atrophy in frontotemporal dementia - Not just a C9orf72 problem","volume":"18","author":"Bocchetta","year":"2018","journal-title":"Neuroimage Clin."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1212\/01.wnl.0000437313.80913.2c","article-title":"Basal ganglia involvement in amyotrophic lateral sclerosis","volume":"81","author":"Bede","year":"2013","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.heares.2009.04.017","article-title":"Multisensory anatomical pathways","volume":"258","author":"Cappe","year":"2009","journal-title":"Hear Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnagi.2018.00045","article-title":"Atrophy in the thalamus but not cerebellum is specific for C9orf72 FTD and ALS Patients - an atlas-based volumetric MRI study","volume":"10","author":"Schonecker","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00401-015-1474-4","article-title":"Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers","volume":"130","author":"Gendron","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S1474-4422(13)70210-2","article-title":"Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study","volume":"12","author":"van Blitterswijk","year":"2013","journal-title":"Lancet Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00401-017-1725-7","article-title":"In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers","volume":"134","author":"DeJesus-Hernandez","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/ene.12675","article-title":"Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images","volume":"22","author":"Whitwell","year":"2015","journal-title":"Eur J Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1152\/jn.00339.2011","article-title":"The organization of the human cerebellum estimated by intrinsic functional connectivity","volume":"106","author":"Buckner","year":"2011","journal-title":"J Neurophysiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ana.24296","article-title":"Longitudinal diffusion tensor imaging in frontotemporal dementia","volume":"77","author":"Mahoney","year":"2015","journal-title":"Ann Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1212\/WNL.0000000000002017","article-title":"Basal ganglia pathology in ALS is associated with neuropsychological deficits","volume":"85","author":"Machts","year":"2015","journal-title":"Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1136\/jnnp-2016-313959","article-title":"Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion","volume":"87","author":"Westeneng","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/archneurol.2008.558","article-title":"Clinical and pathological continuum of multisystem TDP-43 proteinopathies","volume":"66","author":"Geser","year":"2009","journal-title":"Arch Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00401-015-1476-2","article-title":"Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers","volume":"130","author":"Mackenzie","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-017-1793-8","article-title":"Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis","volume":"135","author":"Saberi","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0165084","DOI":"10.1371\/journal.pone.0165084","article-title":"Distinct C9orf72-associated dipeptide repeat structures correlate with neuronal toxicity","volume":"11","author":"Flores","year":"2016","journal-title":"PLoS ONE"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1212\/WNL.0000000000004865","article-title":"Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression","volume":"90","author":"McGoldrick","year":"2018","journal-title":"Neurology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00401-014-1245-7","article-title":"Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability","volume":"127","author":"Proudfoot","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/nan.12178","article-title":"Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene","volume":"41","author":"Baborie","year":"2015","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/jnnp-2017-316799","article-title":"Longitudinal diffusion imaging across the C9orf72 clinical spectrum","volume":"89","author":"Floeter","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.nicl.2016.12.006","article-title":"Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers","volume":"14","author":"Lee","year":"2017","journal-title":"Neuroimage Clin."},{"key":"B48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jamaneurol.2017.4266","article-title":"Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years","volume":"75","author":"Bertrand","year":"2018","journal-title":"JAMA Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2013.221","article-title":"Amyotrophic lateral sclerosis-a model of corticofugal axonal spread","volume":"9","author":"Braak","year":"2013","journal-title":"Nat Rev Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","article-title":"Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)","volume":"127","author":"Brettschneider","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1212\/WNL.0000000000000583","article-title":"Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia","volume":"83","author":"Dopper","year":"2014","journal-title":"Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"W76","DOI":"10.2214\/AJR.13.12363","article-title":"Brain FDG PET and the diagnosis of dementia. AJR","volume":"204","author":"Shivamurthy","year":"2015","journal-title":"Am J Roentgenol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00259-013-2667-5","article-title":"The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients","volume":"41","author":"Cistaro","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamaneurol.2014.62","article-title":"Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study","volume":"71","author":"Van Laere","year":"2014","journal-title":"JAMA Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/13554794.2012.732090","article-title":"The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome","volume":"20","author":"Adeli","year":"2014","journal-title":"Neurocase"},{"key":"B56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/13554794.2012.741252","article-title":"Brain F-FDG and C-PiB PET findings in two siblings with FTD\/ALS associated with the C9ORF72 repeat expansion","volume":"20","author":"Martikainen","year":"2014","journal-title":"Neurocase"},{"key":"B57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s13311-016-0487-6","article-title":"Transcranial magnetic stimulation for the assessment of neurodegenerative disease","volume":"14","author":"Vucic","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1212\/WNL.53.3.605","article-title":"Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease","volume":"53","author":"Triggs","year":"1999","journal-title":"Neurology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jamaneurol.2015.1872","article-title":"Cortical function in asymptomatic carriers and patients with C9orf72 amyotrophic lateral sclerosis","volume":"72","author":"Geevasinga","year":"2015","journal-title":"JAMA Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/mus.25047","article-title":"Cortical hyperexcitability in patients with C9ORF72 mutations: relationship to phenotype","volume":"54","author":"Schanz","year":"2016","journal-title":"Muscle Nerve"},{"key":"B61","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1136\/jnnp-2012-304529","article-title":"Pathophysiological insights into ALS with C9ORF72 expansions","volume":"84","author":"Williams","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fneur.2017.00395","article-title":"Mismatch negativity as an indicator of cognitive sub-domain dysfunction in amyotrophic lateral sclerosis","volume":"8","author":"Iyer","year":"2017","journal-title":"Front Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/mus.24128","article-title":"Electrical impedance myography correlates with standard measures of ALS severity","volume":"49","author":"Rutkove","year":"2014","journal-title":"Muscle Nerve"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/jnnp-2015-310509","article-title":"Tracking motor neuron loss in a set of six muscles in amyotrophic lateral sclerosis using the Motor Unit Number Index (MUNIX): a 15-month longitudinal multicentre trial","volume":"86","author":"Neuwirth","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet Neurol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","article-title":"Hypermetabolism in ALS is associated with greater functional decline and shorter survival","volume":"89","author":"Steyn","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3109\/17482968.2010.482592","article-title":"A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS","volume":"11","author":"Jawaid","year":"2010","journal-title":"Amyotroph Lateral Scler."},{"key":"B68","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","article-title":"Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia","volume":"32","author":"Peter","year":"2017","journal-title":"Eur J Epidemiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/jnnp-2017-315795","article-title":"Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis","volume":"88","author":"Gorges","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13311-016-0503-x","article-title":"Fluid-based biomarkers for amyotrophic lateral sclerosis","volume":"14","author":"Vu","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B71","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.24980","article-title":"Phosphorylated neurofilament heavy chain: a biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis","volume":"82","author":"Gendron","year":"2017","journal-title":"Ann Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1212\/WNL.0000000000004115","article-title":"Disease progression in C9orf72 mutation carriers","volume":"89","author":"Floeter","year":"2017","journal-title":"Neurology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/humu.22211","article-title":"Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide","volume":"34","author":"Garc\u00eda-Redondo","year":"2013","journal-title":"Hum Mutat."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1212\/WNL.0000000000003067","article-title":"Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population","volume":"87","author":"Umoh","year":"2016","journal-title":"Neurology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia","volume":"3","author":"Meeter","year":"2016","journal-title":"Ann Clin Transl Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/acn3.559","article-title":"Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers","volume":"5","author":"Meeter","year":"2018","journal-title":"Ann Clin Transl Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"859","DOI":"10.15252\/emmm.201607486","article-title":"Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS\/FTD","volume":"9","author":"Lehmer","year":"2017","journal-title":"EMBO Mol Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS","volume":"83","author":"Su","year":"2014","journal-title":"Neuron"},{"key":"B81","doi-asserted-by":"publisher","first-page":"eaai7866","DOI":"10.1126\/scitranslmed.aai7866","article-title":"Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis","volume":"9","author":"Gendron","year":"2017","journal-title":"Sci Transl Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"a024224","DOI":"10.1101\/cshperspect.a024224","article-title":"Disease mechanisms of C9ORF72 repeat expansions","volume":"8","author":"Gendron","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00401-015-1480-6","article-title":"Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72","volume":"130","author":"van Blitterswijk","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of toxicity from ALS\/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"B85","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.aaf7791","article-title":"Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts","volume":"353","author":"Kramer","year":"2016","journal-title":"Science"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.01063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T04:27:55Z","timestamp":1543984075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.01063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":85,"alternative-id":["10.3389\/fneur.2018.01063"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.01063","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"article-number":"1063"}}